People in the UK, who currently have significantly poorer access to cancer medicines compared to those in Europei, could soon be gaining access to life saving cancer treatments which are currently not available on the NHS, with the launch of the Cancer Drugs Fund. The interim funding of £50 million for cancer drugs made available today is ahead of the introduction of a longer term Cancer Drugs Fund of £600 million from 2011-2014.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/wishingwall/46284/
EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced that the company’s state-of-the-art research center in Billerica, MA, is LEED® Gold certified under the U.S. Green Building Council and verified by the Green Building Certification Institute (GBCI). LEED® is the nation’s preeminent program for the design, construction and operation of high performance green buildings. The Billerica research facility supports the company’s commitment to developing and discovering innovative treatments in oncology, neurodegenerative diseases and fertility, and is one of only five laboratories in Massachusetts to achieve this high rating.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/emdserono/49715/
Amway’s ARTISTRY® brand has licensed a leading anti-aging technology for its anti-wrinkle firming serum, the newest addition to the ARTISTRY intensive skincare line. This serum will be the first and only anti-aging product to utilize a breakthrough patented Targeting Complex technology that reduces the common side effects found in retinol treatments.
Using exclusive patented technology from the University of Michigan, ARTISTRYintensive skincare anti-wrinkle firming serum combats the visible effects of aging by boosting collagen while minimizing the level of sensitivity associated with retinol use.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54642-amway-artistry-intensive-skincare-line-anti-wrinkle-firming-serum
From Number 1 New York Times bestselling author, Lisa Jackson, comes a pulse pounding thriller novel that takes readers to an exclusive academy for wayward kids. Disturbing rumors of missing students and questionable treatments pale in comparison to the sinister acts being committed by a murderous evil without limits, without remorse, without mercy. Learn more about this book here, http://bit.ly/i5VPWW and its author here, http://www.lisajackson.com
The largest-ever morbi-mortality study of treatments for chronic heart failure has shown that adding the specific heart rate lowering agent Procoralan® (ivabradine) to standard therapy significantly reduces the risk of death and hospitalisation for heart failure.1 Results from this new study, SHIFT (Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial), were presented today at the European Society of Cardiology1 in Stockholm and published in The Lancet.2
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/shift/44195/
FAVORITE HOME REMEDIES FROM THE PEOPLE’S PHARMACY. Discover natural treatments for more than 60 common ailments, plus beneficial foods, diets, and recipes in the new book, The People’s Pharmacy Quick and Handy Home Remedies. Learn more about this book here, http://bit.ly/hySp5Z and its author here, http://peoplespharmacy.com/ Non Fiction, Health, Cookbook
For many women with frizzy, coarse, unruly hair, there’s no limit to what they would spend—or undergo—to achieve sleek, smooth, straight strands. With the advent of keratin-based salon straightening treatments, women are clamoring for the unprecedented smoothing benefits, spending upwards of $250 to experience the dramatic effects the services promise.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/johnfrieda/47819/
It\\\'s that time of year when you may find yourself feeling that dreaded tingle on you lip that you know will eventually turn into a cold sore. Although cold sores can appear on your lip year round due to cold weather, sun exposure, stress, sickness, injury to the mouth or lack of sleep, outbreaks are most prevalent in the winter time. A new, informative and entertaining website, www.MedicineNotMyth.com helps you identify the right treatments that can help you prevent or shorten an outbreak and understand and avoid cold sore triggers.
University Hospitals (UH) Case Medical Center has announced a $250 million initiative that promises to dramatically change how drugs will advance from discovery in the laboratories to commercialization, resulting in greater access to advanced treatments and cures for patients. The first-of-its-kind initiative, named The Harrington Project for Discovery & Development, is powered by a $50 million gift – the largest donation in the health system’s history – from the Harrington family, recognized entrepreneurs and philanthropists in Cleveland.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54909-university-hospitals-uh-harrington-discovery-institute-development-project
EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced the opening of a state-of-the-art research center in Billerica, MA, establishing it as a “hub” within the Merck KGaA research organization. Representing a $65 million investment, the Billerica research facility supports the company’s commitment to developing and discovering innovative treatments in oncology, neurodegenerative diseases and infertility. Nearly 100 new jobs will be added in Massachusetts as a result of the building expansion.
To view Multimedia News Release, go to
http://multivu.prnewswire.com/mnr/emdserono/48166/
http://chiropractorrogersar.com/chiropractor-rogers-ar/back-pain/
Suffering from lower back pain? Go see your chiropractor Rogers AR as soon as possible. These specialists are effective at relieving low back pain. Safe chiropractic Treatments Should Always be Considered Before Risky and Unnecessary Surgery. Chiropractors Restore Mobility and Balance Providing Patients with Effective Pain Relief.
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia.
“We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
